Clinical Trial Update: Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017 [Phase 1]

View source ↗

Summary

Phase 1 trial update describing extended-use protocol for participants with cancer to continue treatment with CS-7017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CS-7017

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-08-14